• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Good Luck Neuro/pysch


<











Really a trip to San Diego for a week and getting an ipad a study ceased ::::: what !?!?!no excitement to be in this division?!

I'll take ur job!!! Without your inept manager.
Plz let all know where your comfort is too much or not enough.